Celltrion, Stock Price +0.64% at This Hour... Institutional Investors Net Sell 377,289 Shares in Last 5 Days

As of 12:31 PM on the 20th, Celltrion is trading at 314,500 KRW, up 0.64% from the previous day. The trading volume is 857,934 shares, which is 26.32% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On January 18, researcher Han Byunghwa from Eugene Investment & Securities stated, "The success of the Phase 2 COVID-19 antibody treatment trial is sufficient for emergency approval overseas. Emergency approval and exports abroad are expected to occur simultaneously in the second quarter. Celltrion has demonstrated the capability to compete with global big pharma in a short period. Repeated pandemics will enable Celltrion to develop a second Regkirona injection, providing two growth engines in the new drug and biosimilar markets. The definite fact is that Celltrion has shown development capabilities on par with global big pharma." He set Celltrion's target price at 400,000 KRW.

Over the past five days, individual investors have net purchased 376,879 shares of Celltrion, while foreigners and institutions have net sold 39,126 shares and 377,289 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.